| 000 | 01725 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516014609.0 | ||
| 264 | 0 | _c20110310 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a2146-8427 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbdallah, Taieb Ben | |
| 245 | 0 | 0 |
_aThe role of generics in kidney transplant: mycophenolate mofetil 500 versus mycophenolate: 2-year results. _h[electronic resource] |
| 260 |
_bExperimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation _cDec 2010 |
||
| 300 |
_a292-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 |
_aDrugs, Generic _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft Rejection _ximmunology |
| 650 | 0 | 4 |
_aGraft Survival _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycophenolic Acid _xadverse effects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTunisia |
| 700 | 1 | _aOunissi, Mondher | |
| 700 | 1 | _aCherif, Mejda | |
| 700 | 1 | _aHelal, Imed | |
| 700 | 1 | _aKaroui, Cyrine | |
| 700 | 1 | _aMhibik, Sonia | |
| 700 | 1 | _aBacha, Med Mongi | |
| 700 | 1 | _aAbderrahim, Ezzeddine | |
| 700 | 1 | _aKheder, Adel | |
| 773 | 0 |
_tExperimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation _gvol. 8 _gno. 4 _gp. 292-6 |
|
| 999 |
_c20433554 _d20433554 |
||